ARTICLE | Company News
Isis, GlaxoSmithKline deal
August 2, 2010 7:00 AM UTC
Isis received a $5 million milestone payment from GlaxoSmithKline under a March deal in which the companies partnered to discover and develop up to six undisclosed preclinical therapeutics using Isis'...